The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
Abstract
Treatments for invasive fungal infections remain unsatisfactory. We evaluated the efficacy, tolerability, and safety of voriconazole as salvage treatment for 273 patients with refractory and intolerant-to-treatment fungal infections and as primary treatment for 28 patients with infections for which there is no approved therapy. Voriconazole was associated with satisfactory global responses in 50% of the overall cohort; specifically, successful outcomes were observed in 47% of patients whose infections failed to respond to previous antifungal therapy and in 68% of patients whose infections have no approved antifungal therapy. In this population at high risk for treatment failure, the efficacy rates for voriconazole were 43.7% for aspergillosis, 57.5% for candidiasis, 38.9% for cryptococcosis, 45.5% for fusariosis, and 30% for scedosporiosis. Voriconazole was well tolerated, and treatment-related discontinuations of therapy or dose reductions occurred for <10% of patients. Voriconazole is an effective and well-tolerated treatment for refractory or less-common invasive fungal infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citationEpidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448
Self-citationAspergillosis Case-Fatality Rate: Systematic Review of the Literature
Lin, S.-J., Schranz, J., & Teutsch, S. M. (2001) · Clinical Infectious Diseases · doi:10.1086/318483 · Cited by 1,409
Modelling Survival Data in Medical Research
Collett, D. (1994) · Springer eBooks · doi:10.1007/978-1-4899-3115-3 · Cited by 1,065
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Self-citationAntifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
Denning, D. W., & Stevens, D. A. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.6.1147 · Cited by 899
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
Denning, D. W., Ribaud, P., Milpied, N., Caillot, D., Herbrecht, R., Thiel, E., Haas, A., Ruhnke, M., & Lode, H. (2002) · Clinical Infectious Diseases · doi:10.1086/324620 · Cited by 844
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine · doi:10.1097/00005792-200007000-00006 · Cited by 791
Self-citationWalsh, T. J., Hiemenz, J. W., Seibel, N. L., Perfect, J. R., Horwith, G., Lee, L., Silber, J. L., DiNubile, M. J., Reboli, A., Bow, E., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516353 · Cited by 629
Self-citationThe Impact of Culture Isolation of Aspergillus Species: A Hospital‐Based Survey of Aspergillosis
Perfect, J. R., Cox, G. M., Lee, J. Y., Kauffman, C. A., de Repentigny, L., Chapman, S. W., Morrison, V. A., Pappas, P., Hiemenz, J. W., Stevens, D. A., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/323900 · Cited by 458
Self-citationWALSH, T. J., LUTSAR, I., DRISCOLL, T., DUPONT, B., RODEN, M., GHAHRAMANI, P., HODGES, M., GROLL, A. H., & PERFECT, J. R. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200203000-00015 · Cited by 431
Self-citationEspinel-Ingroff, A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.1.198-202.1998 · Cited by 361
Self-citationAlly, R., Schürmann, D., Kreisel, W., Carosi, G., Aguirrebengoa, K., Dupont, B., Hodges, M., Troke, P., Romero, A. J., & the Esophageal Candidiasis Study Group (2001) · Clinical Infectious Diseases · doi:10.1086/322653 · Cited by 331
Espinel-Ingroff, A. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.3.954-958.2001 · Cited by 296
Self-citationEspinel-Ingroff, A., Boyle, K., & Sheehan, D. J. (2001) · Mycopathologia · doi:10.1023/a:1010954803886 · Cited by 251
Self-citationEspinel-Ingroff, A., Bartlett, M., Bowden, R., Chin, N. X., Cooper, C., Fothergill, A., McGinnis, M. R., Menezes, P., Messer, S. A., Nelson, P. W., et al. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.1.139-143.1997 · Cited by 228
Self-citationNesky, M. A., McDougal, E. C., & Peacock, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/314042 · Cited by 214
Schwartz, S., Milatovic, D., & Thiel, E. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.972911.x · Cited by 164
Aspergillus Meningitis: Diagnosis by Non-Culture-Based Microbiological Methods and Management
Verweij, P. E., Brinkman, K., Kremer, H. P. H., Kullberg, B.-J., & Meis, J. F. G. M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.4.1186-1189.1999 · Cited by 159
Epidemiology of fungal infections in solid organ transplant patients
PATTERSON, J. E. (1999) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.1999.010402.x · Cited by 123
Use of Voriconazole in Treatment of Scedosporium apiospermum Infection: Case Report
Girmenia, C., Luzi, G., Monaco, M., & Martino, P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.5.1436-1438.1998 · Cited by 123
Muñóz, P., Marín, M., Tornero, P., Martín‐Rabadán, P., Rodríguez-Créixems, M., & Bouza, E. (2000) · Clinical Infectious Diseases · doi:10.1086/317496 · Cited by 122
REIS, A. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.8.928d · Cited by 110
The search for new triazole antifungal agents
Koltin, Y., & Hitchcock, C. A. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80007-5 · Cited by 110
Potoski, B. A., & Brown, J. E. (2002) · Clinical Infectious Diseases · doi:10.1086/343746 · Cited by 88
Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
Hegener, P., Troke, P. F., Fätkenheuer, G., Diehl, V., & Ruhnke, M. (1998) · PubMed · Cited by 78
Machetti, M., Zotti, M., Veroni, L., Mordini, N., Lint, M. T. V., Bacigalupo, A. P., Paola, D. G. D., & Viscoli, C. (2000) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2000.020307.x · Cited by 69
Successful Treatment with Voriconazole of Invasive Aspergillosis in Chronic Granulomatous Disease
Hek, L. V. '., Verweij, P. E., Weemaes, C. M. R., van Dalen, R., Yntema, J.-B. L., & Meis, J. F. G. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709068 · Cited by 65
Linden, P., Williams, P. A., & Chan, K. M. (2000) · Clinical Transplantation · doi:10.1034/j.1399-0012.2000.140409.x · Cited by 61
Hilmarsdóttir, I. (2000) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540050166063 · Cited by 49
Fungal Infections in Patients With Neutropenia: Challenges in Prophylaxis and Treatment
Herbrecht, R., Neuville, S., Letscher‐Bru, V., Natarajan‐Amé, S., & Lortholary, O. (2000) · Drugs & Aging · doi:10.2165/00002512-200017050-00002 · Cited by 35
de Sévaux, R. G. L., Kullberg, B. J., Verweij, P. E., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/517646 · Cited by 20
Breakthrough Fungemia Appearing during Empiric Therapy with Amphotericin B
Krcmery, V., Spanik, S., Kunova, A., et al. (2009) · Chemotherapy · doi:10.1159/000239591 · Cited by 14
Cited by
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citationWalsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Self-citationPerfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Self-citationUllmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Novel perspectives on mucormycosis: pathophysiology, presentation, and management
Spellberg, B., Edwards, J., & Ibrahim, A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.556-569.2005 · Cited by 1,537
Metadata
- Authors
- Perfect, J. R., Marr, K. A., Walsh, T. J., Greenberg, R. N., DuPont, B., de la Torre‐Cisneros, J., Just‐Nubling, G., Schlamm, H. T., Lutsar, I., Espinel‐Ingroff, A., & Johnson, E.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-05
- Volume
- 36
- Issue
- 9
- Pages
- 1122-1131
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2087548480
- Cited by
- 680
- References
- 34
- FWCI
- 33.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.